The world is embracing medical aesthetics more than ever, so the new investment will be a valuable asset as MedShift continues to move the needle in the industry. After finishing 2020 as the 15th fastest growing health company in the US Inc 5000 ranking, MedShift expects revenues to surpass $21 million in 2021. MedShift’s portfolio has grown immensely since its founding in 2015 and currently spans over thirty devices, four sister brands, and more than 400 partner practices across North America. Aside from MedShift’s lengthy medical technology device portfolio, the enterprise software division has seen tremendous growth with new integrations to Oracle, SAP, Microsoft, as well as other financial platforms. Some of the largest medical manufacturers in the world now leverage MedShift enterprise software for seamless fully integrated payment facilitation and digitized product ordering.
Announces Completion of $8 Million Equity Raise —